Brister Mark 4
4 · OBALON THERAPEUTICS INC · Filed Oct 28, 2019
Insider Transaction Report
Form 4
Brister Mark
VP of Research and Development
Transactions
- Award
Stock Option (Right to Buy)
2019-10-25+13,000→ 13,000 totalExercise: $1.75Exp: 2029-10-25→ Common Stock (13,000 underlying)
Footnotes (1)
- [F1]The Option shall vest as to 1/48th of the Shares underlying the Option on each monthly anniversary of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date.